Education
About Us
Working with TipRanks
Follow Us
James William Kupiec Insider Profile
11 Followers
James William Kupiec, CMO at Filana Therapeutics, holds 0.00 shares in Filana Therapeutics (Ticker: FLNA). Most recently, James William Kupiec Sold 4,000 shares of Filana Therapeutics on Dec 03, 2024 for an estimated value of $15.48K.
Profitable Transactions
1 out of 2 Profitable Transactions
Average Return
-13.20%
Average return per transaction
Time Frame
Compare to
Insider Holdings
James William Kupiec does not currently own shares as a corporate insider.
A breakdown of James William Kupiec's holdings
Insider Roles
CMO
Roles that James William Kupiec holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Dec 03, 2024 - Dec 03, 2025
Return:+7.40%
The most profitable trade made by James William Kupiec
James William Kupiec's Trading History
List of latest transactions for each holding click on a transaction to see James William Kupiec's performance on stock
You May Also Like
James William Kupiec insider profile FAQ
What is the percentage of profitable transactions made by James William Kupiec?
The percentage of profitable transactions made by James William Kupiec is 50%.
What is the average return per transaction made by James William Kupiec?
The average return per transaction made by James William Kupiec is -13.20%.
What stocks does James William Kupiec hold?
James William Kupiec holds: FLNA stocks.
What was James William Kupiec’s latest transaction?
James William Kupiec latest transaction was an Informative Sell of $15.48K.
What was James William Kupiec's most profitable transaction?
James William Kupiec’s most profitable transaction was an Informative Sell of FLNA stock on December 3, 2024. The return on the trade was 7.40%.
What is James William Kupiec's role in Filana Therapeutics?
James William Kupiec's role in Filana Therapeutics is CMO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.